Movement Alert｜ImmunityBio, Inc. falls 5.75% in Regular Trading, trading at $9.46

Market Focus10-16

On October 16, ImmunityBio, Inc. fell 5.75% in Regular Trading, trading at $9.46 per share, with turnover of $20.5133 million.

Within the Biotechnology sector where ImmunityBio, Inc. belongs, peer performance was mixed. Among individual stocks, Moderna, Inc. fell 6.22%, AbbVie rose 0.2%, Amgen rose 0.43%, Gilead Sciences fell 0.67%, and Vertex Pharmaceuticals fell 0.12%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment